173 related articles for article (PubMed ID: 18771811)
1. A verification study of proposed pelvic lymph node localisation guidelines using nanoparticle-enhanced magnetic resonance imaging.
Vilarino-Varela MJ; Taylor A; Rockall AG; Reznek RH; Powell ME
Radiother Oncol; 2008 Nov; 89(2):192-6. PubMed ID: 18771811
[TBL] [Abstract][Full Text] [Related]
2. Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging.
Dinniwell R; Chan P; Czarnota G; Haider MA; Jhaveri K; Jewett M; Fyles A; Jaffray D; Milosevic M
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):844-51. PubMed ID: 19095369
[TBL] [Abstract][Full Text] [Related]
3. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy.
Taylor A; Rockall AG; Reznek RH; Powell ME
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1604-12. PubMed ID: 16198509
[TBL] [Abstract][Full Text] [Related]
4. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
Memarsadeghi M; Riedl CC; Kaneider A; Galid A; Rudas M; Matzek W; Helbich TH
Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065
[TBL] [Abstract][Full Text] [Related]
5. Does quantification of USPIO uptake-related signal loss allow differentiation of benign and malignant normal-sized pelvic lymph nodes?
Froehlich JM; Triantafyllou M; Fleischmann A; Vermathen P; Thalmann GN; Thoeny HC
Contrast Media Mol Imaging; 2012; 7(3):346-55. PubMed ID: 22539405
[TBL] [Abstract][Full Text] [Related]
6. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients.
Thoeny HC; Triantafyllou M; Birkhaeuser FD; Froehlich JM; Tshering DW; Binser T; Fleischmann A; Vermathen P; Studer UE
Eur Urol; 2009 Apr; 55(4):761-9. PubMed ID: 19144456
[TBL] [Abstract][Full Text] [Related]
7. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation.
Harisinghani MG; Saini S; Weissleder R; Hahn PF; Yantiss RK; Tempany C; Wood BJ; Mueller PR
AJR Am J Roentgenol; 1999 May; 172(5):1347-51. PubMed ID: 10227514
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO): diagnostic performance in post-contrast images using new diagnostic criteria.
Tokuhara T; Tanigawa N; Matsuki M; Nomura E; Mabuchi H; Lee SW; Tatsumi Y; Nishimura H; Yoshinaka R; Kurisu Y; Narabayashi I
Gastric Cancer; 2008; 11(4):194-200. PubMed ID: 19132480
[TBL] [Abstract][Full Text] [Related]
9. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer.
Birkhäuser FD; Studer UE; Froehlich JM; Triantafyllou M; Bains LJ; Petralia G; Vermathen P; Fleischmann A; Thoeny HC
Eur Urol; 2013 Dec; 64(6):953-60. PubMed ID: 23916692
[TBL] [Abstract][Full Text] [Related]
10. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.
Choi SH; Moon WK; Hong JH; Son KR; Cho N; Kwon BJ; Lee JJ; Chung JK; Min HS; Park SH
Radiology; 2007 Jan; 242(1):137-43. PubMed ID: 17090719
[TBL] [Abstract][Full Text] [Related]
11. USPIO-enhanced MRI of pelvic lymph nodes at 7-T: preliminary experience.
Philips BWJ; Stijns RCH; Rietsch SHG; Brunheim S; Barentsz JO; Fortuin AS; Quick HH; Orzada S; Maas MC; Scheenen TWJ
Eur Radiol; 2019 Dec; 29(12):6529-6538. PubMed ID: 31201525
[TBL] [Abstract][Full Text] [Related]
12. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
Deserno WM; Harisinghani MG; Taupitz M; Jager GJ; Witjes JA; Mulders PF; Hulsbergen van de Kaa CA; Kaufmann D; Barentsz JO
Radiology; 2004 Nov; 233(2):449-56. PubMed ID: 15375228
[TBL] [Abstract][Full Text] [Related]
13. MR imaging staging of pelvic lymph nodes.
Kim JY; Harisinghani MG
Magn Reson Imaging Clin N Am; 2004 Aug; 12(3):581-6. PubMed ID: 15271372
[TBL] [Abstract][Full Text] [Related]
14. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings--initial observations.
Koh DM; Brown G; Temple L; Raja A; Toomey P; Bett N; Norman AR; Husband JE
Radiology; 2004 Apr; 231(1):91-9. PubMed ID: 14976266
[TBL] [Abstract][Full Text] [Related]
15. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10.
Tatsumi Y; Tanigawa N; Nishimura H; Nomura E; Mabuchi H; Matsuki M; Narabayashi I
Gastric Cancer; 2006; 9(2):120-8. PubMed ID: 16767368
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography.
Bellin MF; Lebleu L; Meric JB
Abdom Imaging; 2003; 28(2):155-63. PubMed ID: 12592461
[TBL] [Abstract][Full Text] [Related]
17. High-Accuracy Nodal Staging of Head and Neck Cancer With USPIO-Enhanced MRI: A New Reading Algorithm Based on Node-to-Node Matched Histopathology.
Driessen DAJJ; Zámecnik P; Dijkema T; Pegge SAH; van Engen-van Grunsven ACH; Takes RP; Kaanders JHAM; Scheenen TWJ
Invest Radiol; 2022 Dec; 57(12):810-818. PubMed ID: 35776432
[TBL] [Abstract][Full Text] [Related]
18. USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: preliminary results.
Keller TM; Michel SC; Fröhlich J; Fink D; Caduff R; Marincek B; Kubik-Huch RA
Eur Radiol; 2004 Jun; 14(6):937-44. PubMed ID: 14991323
[TBL] [Abstract][Full Text] [Related]
19. Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience.
Bellin MF; Roy C; Kinkel K; Thoumas D; Zaim S; Vanel D; Tuchmann C; Richard F; Jacqmin D; Delcourt A; Challier E; Lebret T; Cluzel P
Radiology; 1998 Jun; 207(3):799-808. PubMed ID: 9609907
[TBL] [Abstract][Full Text] [Related]
20. Overview of nanoparticle use in cancer imaging.
Islam T; Harisinghani MG
Cancer Biomark; 2009; 5(2):61-7. PubMed ID: 19414922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
